bbin宝盈集团

      Global
      关于bbin宝盈集团

      致力于纳米抗体
      创新药物研发

      关于bbin宝盈集团
      科研论文
      截止现在，bbin宝盈集团生物研发团队在具有重要影响力的期刊上发表研究论文多篇。
      2024-12-03
      Efficient development of nanobody-based affinity chromatography for AAV8 purification.
      发表于:Protein Expression and Purification
      查看更多内容
      2024-10-30
      Ce-MOF@Au-Based Electrochemical Immunosensor for Apolipoprotein A1 Detection Using Nanobody Technology.
      发表于:ACS Applied Materials & Interfaces
      查看更多内容
      2024-06-11
      A novel inhalable nanobody targeting IL-4Rα for the treatment of asthma.
      发表于:J Allergy Clin Immunol.
      查看更多内容
      2024-06-10
      Nanobody-Based Microfluidic Immunosensor Chip Using Tetraphenylethylene-Derived Covalent Organic Frameworks as Aggregation-Induced Electrochemiluminescence Emitters for the Detection of Thymic Stromal Lymphopoietin.
      发表于:Analytical Chemistry
      查看更多内容
      2024-05-16
      A humanized trivalent Nectin-4-targeting nanobody drug conjugate displays potent antitumor activity in gastric cancer.
      发表于:Journal of Nanobiotechnology.
      查看更多内容
      2024-02-16
      High performance production process development and scale-up of ananti-TSLP nanobody
      发表于:Protein expression and purification, 218, 106441.
      查看更多内容
      总计 24 1234